PIN29 Cost Effectiveness Analysis of Addition of Telaprevir or Boceprevir to Standard Therapy Versus Standard Therapy Alone for the Treatment of Previously Untreated Chronic Hepatitis-C Virus Genotype 1 Infection

Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12871 ◽

2014 ◽

Vol 40 (6) ◽

pp. 657-675 ◽

Cited By ~ 50

Author(s):

S. Saab ◽

S. C. Gordon ◽

H. Park ◽

M. Sulkowski ◽

A. Ahmed ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal

Applied Health Economics and Health Policy ◽

10.1007/s40258-012-0007-8 ◽

2013 ◽

Vol 11 (1) ◽

pp. 65-78 ◽

Cited By ~ 28

Author(s):

Elamin H. Elbasha ◽

Jagpreet Chhatwal ◽

Shannon A. Ferrante ◽

Antoine C. El Khoury ◽

Pedro A. Laires

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin Regimen for Patients Infected With Chronic Hepatitis C Virus Genotype 1 in Malaysia

Value in Health Regional Issues ◽

10.1016/j.vhri.2019.09.005 ◽

2020 ◽

Vol 21 ◽

pp. 164-171

Author(s):

Asrul Akmal Shafie ◽

Muhammad Radzi Abu Hassan ◽

Siew Chin Ong ◽

Suchin Virabhak ◽

Yuri Sanchez Gonzalez

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Faculty Opinions recommendation of Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718509362.793497944 ◽

2014 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.13081 ◽

2015 ◽

Vol 41 (6) ◽

pp. 544-563 ◽

Cited By ~ 84

Author(s):

Z. M. Younossi ◽

H. Park ◽

S. Saab ◽

A. Ahmed ◽

D. Dieterich ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

IL28B genetic variation and ratio of y-GT/ALT as predictors for virological response in chronic hepatitis C virus genotype 1 infected patients

Zeitschrift für Gastroenterologie ◽

10.1055/s-0031-1295892 ◽

2012 ◽

Vol 50 (01) ◽

Author(s):

A Amanzada ◽

S Schneider ◽

F Moriconi ◽

M Blaschke ◽

T Suermann ◽

...

Keyword(s):

Genetic Variation ◽

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virological Response ◽

Genotype 1 ◽

Virus Genotype ◽

Faculty Opinions recommendation of Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718061915.793484659 ◽

2013 ◽

Author(s):

Cihan Yurdaydin

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Randomized Trial ◽

Dose Reduction ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Head-to-head clinical Trial of Sofosbuvir plus Daclatasvir or Simeprevir for 12 weeks in Non-cirrhotic subjects with significant fibrosis infected with chronic Hepatitis C Virus genoType 1 (TNT-1 Study)

International Journal of Infectious Diseases ◽

10.1016/j.ijid.2018.04.4264 ◽

2018 ◽

Vol 73 ◽

pp. 376

Author(s):

H. Pott Junior ◽

G. Bricks ◽

G. Grandi ◽

J. Senise ◽

A. Castelo

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Significant Fibrosis ◽

Cost-Effectiveness of Elbasvir/Grazoprevir Versus Daclatasvir Plus Asunaprevir in Patients with Chronic Hepatitis C Virus Genotype 1b Infection in China

Clinical Drug Investigation ◽

10.1007/s40261-018-0702-9 ◽

2018 ◽

Vol 38 (11) ◽

pp. 1031-1039 ◽

Cited By ~ 6

Author(s):

Pingyu Chen ◽

Aixia Ma ◽

Qiang Liu

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Genotype 1B ◽

Cost Effectiveness of Daclatasvir Plus Asunaprevir Therapy for Chinese Patients with Chronic Hepatitis C Virus Genotype 1b

Clinical Drug Investigation ◽

10.1007/s40261-018-0621-9 ◽

2018 ◽

Vol 38 (5) ◽

pp. 427-437 ◽

Cited By ~ 10

Author(s):

Yuchen Liu ◽

Zhenhua Wang ◽

Ruoyan Gai Tobe ◽

Houwen Lin ◽

Bin Wu

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Chinese Patients ◽

Virus Genotype ◽

Genotype 1B ◽